PAVmed (PAVM) Free Cash Flow (2015 - 2025)

PAVmed's Free Cash Flow history runs 11 years deep, the most recent figure standing at -$1.5 million for Q4 2025.

• On a quarterly basis, Free Cash Flow fell 1782.22% year-over-year to -$1.5 million in Q4 2025; TTM through Dec 2025 was -$5.2 million, a 78.84% increase from a year earlier, with the FY2025 full-year figure at -$5.2 million, up 84.44% from the prior year.
• Free Cash Flow retreated to -$1.5 million in Q4 2025 per PAVM's latest filing, from -$903000.0 in the prior quarter.
• Across five years, Free Cash Flow topped out at $90000.0 in Q4 2024 and bottomed at -$22.9 million in Q2 2022.
• The 5-year median for Free Cash Flow is -$11.7 million (2024), against an average of -$10.4 million.
• Across the five-year window, Free Cash Flow surged 100.75% in 2024 and plunged 1782.22% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at -$18.1 million in 2021, then climbed by 5.17% to -$17.1 million in 2022, then rose by 29.58% to -$12.1 million in 2023, then jumped by 100.75% to $90000.0 in 2024, then plunged by 1782.22% to -$1.5 million in 2025.
• Per Business Quant, the three latest PAVM Free Cash Flow figures stand at -$1.5 million (Q4 2025), -$903000.0 (Q3 2025), and -$1.2 million (Q2 2025).